breast cancer - HER2-positive | breast cancer - HR positive | |
la/mBC - HER2 positive - 2nd Line (L2) | la/mBC - HR-positive - 1st line (L1) | |
lapatinib based treatment | ||
lapatinib plus capecitabine | ||
lapatinib plus fulvestrant | ||
lapatinib plus letrozole | ||
lapatinib plus trastuzumab | EGF104900 |